MHP SE financials
MHP SE
Country: GB Reporting currency: USD Latest annual report: 2025-12-31
LEI:
213800D7DXFXGA292757 Financial statements
(USD, as reported — unscaled; 117 line items across 2 annual periods)
| Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | $3.77B | $3.05B |
| Cost of sales | $2.90B | $2.33B |
| Gross profit | $900.0M | $848.0M |
| Other income | $31.0M | $16.0M |
| Operating profit (EBIT) | $376.0M | $413.0M |
| Finance costs | $171.0M | $160.0M |
| Profit before tax | $212.0M | $149.0M |
| Income tax expense | $25.0M | $5.0M |
| Profit for the year | $187.0M | $144.0M |
| — attributable to owners | $175.0M | $134.0M |
| — attributable to NCI | $12.0M | $10.0M |
| Total comprehensive income | $234.0M | $398.0M |
| Per share | ||
| Basic EPS | $1.63 | $1.25 |
| Diluted EPS | $1.63 | $1.25 |
| Free cash flow / share | $-0.03 | $-0.38 |
| Cash flow statement | ||
| Cash generated from operations | $461.0M | $408.0M |
| Net cash from operating activities | $271.0M | $246.0M |
| Net cash from investing activities | -$541.0M | -$333.0M |
| Purchase of PP&E (capex) | $275.0M | $290.0M |
| Net cash from financing activities | $298.0M | $17.0M |
| Proceeds from borrowings | $674.0M | $589.0M |
| Repayments of borrowings | $335.0M | $202.0M |
| Lease liability payments | $41.0M | $28.0M |
| Net change in cash | $28.0M | -$70.0M |
| Balance sheet | ||
| Total assets | $5.45B | $4.43B |
| Non-current assets | $3.28B | $2.76B |
| Property, plant & equipment | $2.66B | $2.30B |
| Right-of-use assets | $307.0M | $266.0M |
| Intangible assets & goodwill | $121.0M | $65.0M |
| Current assets | $2.16B | $1.67B |
| Inventories | $497.0M | $381.0M |
| Trade & other receivables | $327.0M | $200.0M |
| Cash & equivalents | $415.0M | $355.0M |
| Total equity | $2.21B | $1.97B |
| — attributable to owners | $2.16B | $1.94B |
| Non-controlling interests | $52.0M | $26.0M |
| Non-current liabilities | $1.60B | $1.79B |
| Lease liabilities (non-current) | $228.0M | $197.0M |
| Current liabilities | $1.63B | $665.0M |
| Lease liabilities (current) | $95.0M | $79.0M |
| Deferred tax liabilities | $192.0M | $169.0M |
| Derived metrics | ||
| Free cash flow | -$4.0M | -$44.0M |
| Operating margin | 10.0% | 13.6% |
| Net margin | 5.0% | 4.7% |
| Return on equity | 8.4% | 7.3% |
| Cash conversion ratio | 1.45× | 1.71× |
| Capex coverage | 0.99× | 0.85× |
| Other reported items | ||
| Additional Paidin Capital | $174.0M | $174.0M |
| Adjustments For Decrease Increase In Biological Assets | -$26.0M | -$24.0M |
| Adjustments For Decrease Increase In Inventories | -$78.0M | -$76.0M |
| Adjustments For Decrease Increase In Other Current Assets | -$12.0M | $2.0M |
| Adjustments For Decrease Increase In Trade Account Receivable | -$34.0M | -$22.0M |
| Adjustments For Depreciation and Amortisation Expense | $265.0M | $192.0M |
| Adjustments For Finance Costs | $171.0M | $160.0M |
| Adjustments For Finance Income | $19.0M | $21.0M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | $0 | $27.0M |
| Adjustments For Increase Decrease In Contract Liabilities | $16.0M | $9.0M |
| Adjustments For Increase Decrease In Other Current Liabilities | $20.0M | $36.0M |
| Adjustments For Increase Decrease In Trade Account Payable | $31.0M | $7.0M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -$17.0M | $4.0M |
| Adjustments For Unrealised Foreign Exchange Losses Gains | $12.0M | $125.0M |
| Cash Advances and Loans Made To Other Parties Classified As Investing Activities | $5.0M | $13.0M |
| Cash Flows From Used In Operations Before Changes In Working Capital | $603.0M | $505.0M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | $276.0M | $14.0M |
| Cash Receipts From Repayment of Advances and Loans Made To Other Parties Classified As Investing Activities | $5.0M | $2.0M |
| Comprehensive Income Attributable To Noncontrolling Interests | $12.0M | $15.0M |
| Comprehensive Income Attributable To Owners of Parent | $222.0M | $383.0M |
| Current Agricultural Produce | $425.0M | $437.0M |
| Current Biological Assets | $323.0M | $169.0M |
| Current Bonds Issued and Current Portion of Noncurrent Bonds Issued | $549.0M | $0 |
| Current Contract Liabilities | $40.0M | $24.0M |
| Current Interest Payable | $24.0M | $24.0M |
| Current Loans Received and Current Portion of Noncurrent Loans Received | $486.0M | $271.0M |
| Current Prepayments | $69.0M | $47.0M |
| Current Tax Assets Current | $75.0M | $57.0M |
| Deferred Tax Assets | $0 | $1.0M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | $32.0M | -$11.0M |
| Equity and Liabilities | $5.45B | $4.43B |
| Finance Income | $19.0M | $21.0M |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | -$12.0M | -$125.0M |
| Gains Losses On Initial Recognition of Biological Assets For Current Period | $32.0M | $135.0M |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | $0 | $27.0M |
| Income Taxes Paid Refund Classified As Operating Activities | $35.0M | $15.0M |
| Increase Decrease Through Acquisition of Subsidiary | $14.0M | $1.0M |
| Increase Decrease Through Appropriation of Retained Earnings | $0 | $0 |
| Increase Decrease Through Transfer Between Revaluation Reserve and Retained Earnings | $0 | $0 |
| Intangible Assets Other Than Goodwill | $106.0M | $66.0M |
| Interest Paid Classified As Operating Activities | $169.0M | $157.0M |
| Interest Received Classified As Operating Activities | $14.0M | $10.0M |
| Investments In Associates Accounted For Using Equity Method | $17.0M | $21.0M |
| Issued Capital | $285.0M | $285.0M |
| Liabilities | $3.23B | $2.46B |
| Noncurrent Biological Assets | $54.0M | $31.0M |
| Noncurrent Deferred Income Other Than Noncurrent Contract Liabilities | $47.0M | $37.0M |
| Noncurrent Financial Assets | $18.0M | $10.0M |
| Noncurrent Portion of Noncurrent Bonds Issued | $349.0M | $894.0M |
| Noncurrent Portion of Noncurrent Loans Received | $773.0M | $492.0M |
| Other Adjustments For Noncash Items | -$6.0M | -$2.0M |
| Other Comprehensive Income | $47.0M | $254.0M |
| Other Comprehensive Income Before Tax Gains Losses On Revaluation | $0 | $454.0M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | $47.0M | -$131.0M |
| Other Current Financial Assets | $33.0M | $19.0M |
| Other Current Liabilities | $160.0M | $120.0M |
| Other Expense By Function | $94.0M | $76.0M |
| Other Inflows Outflows of Cash Classified As Investing Activities | $4.0M | $0 |
| Other Noncurrent Liabilities | $11.0M | $6.0M |
| Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | $27.0M | $5.0M |
| Proceeds From Sales Or Maturity of Financial Instruments Classified As Investing Activities | $1.0M | $15.0M |
| Purchase of Interests In Associates | $4.0M | $23.0M |
| Purchase of Other Longterm Assets Classified As Investing Activities | $18.0M | $15.0M |
| Repayments of Bonds Notes and Debentures | $0 | $342.0M |
| Reserve of Exchange Differences On Translation | -$1.44B | -$1.49B |
| Retained Earnings | $2.34B | $2.05B |
| Revaluation Surplus | $850.0M | $960.0M |
| Selling General and Administrative Expense | $461.0M | $348.0M |
| Trade and Other Current Payables To Trade Suppliers | $277.0M | $147.0M |
| Treasury Shares | $45.0M | $45.0M |
Methodology
Every line item above is a fact tagged in MHP SE's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (USD), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.